Epilepsy in the elderly

Annals of the New York Academy of Sciences

Volumn 1184, Issue , 2010, Pages 208-224

  Leppik, Ilo E ^a,b   Birnbaum, Angela K ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MINCEP Epilepsy Care   (United States)

Author keywords

Elderly; Epilepsy; Nursing homes; Treatment

Indexed keywords

ANTACID AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CIMETIDINE; DEXTROPROPOXYPHENE; ERYTHROMYCIN; ETIRACETAM; FELBAMATE; FLUOXETINE; GABAPENTIN; KETOCONAZOLE; LAMOTRIGINE; NORFLUOXETINE; OXCARBAZEPINE; PAROXETINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; THYROID HORMONE DERIVATIVE; TOPIRAMATE; UNINDEXED DRUG; VALPROIC ACID; WARFARIN; ZONISAMIDE;

AGED; ALZHEIMER DISEASE; ATAXIA; BALANCE IMPAIRMENT; BRAIN TUMOR; CLINICAL TRIAL; COGNITIVE DEFECT; COMPLEX PARTIAL SEIZURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; DEPRESSION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ELIMINATION; DRUG ERUPTION; DRUG HALF LIFE; DRUG METABOLISM; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; EPILEPSY; EPILEPTOGENESIS; FALLING; FRACTURE; HEAD INJURY; HEART CONDUCTION; HUMAN; HYPONATREMIA; KIDNEY CLEARANCE; LIVER METABOLISM; LOW DRUG DOSE; MAXIMUM PLASMA CONCENTRATION; NEURALGIA; NEUROBIOLOGY; NEUROPATHY; NEUTROPENIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; OSTEOPOROSIS; PATIENT COMPLIANCE; PHARMACOEPIDEMIOLOGY; PROTEIN BINDING; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEDATION; SEIZURE; SEIZURE SUSCEPTIBILITY; SIDE EFFECT; SOMNOLENCE; STROKE; TIME TO MAXIMUM PLASMA CONCENTRATION; TRANSGENIC MOUSE; UNSPECIFIED SIDE EFFECT; ADOLESCENT; ADULT; AGING; ANIMAL; CHILD; DISEASE MODEL; HEALTH STATUS; INCIDENCE; MIDDLE AGED; MOUSE; PHYSIOLOGY; PREVALENCE; UNITED STATES;

ADOLESCENT; AGED; AGED, 80 AND OVER; AGING; ANIMALS; CHILD; DISEASE MODELS, ANIMAL; EPILEPSY; HEALTH STATUS; HUMANS; INCIDENCE; MICE; MICE, TRANSGENIC; MIDDLE AGED; NEUROBIOLOGY; PREVALENCE; UNITED STATES; YOUNG ADULT;

EID: 77949886262     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05113.x     Document Type: Review

References (100)

1. Administration on Aging. 2005. Washington, DC.
2. Hauser, W. & D. Hesdorffer. 1990. Epilepsy, Frequency, Causes and Consequences. Demos Publications. New York, NY.
3. Hauser, W.A., J.F. Annegers & W.A. Rocca. 1996. Mayo. Clin. Proc. 71: 576-586.
4. Epilepsy Foundation of America. 1999. Epilepsy, a Report to the Nation. Epilepsy Foundation of America. Landover, MD.
5. de la Court, A., M.M. Breteler, H. Meinardi, et al. 1996. Epilepsia 37: 141-147.
6. Sillanpaa, M., R. Kalviainen, X Klaukka, et al 2006. Epilepsy Res. 71:206-215.
7. Fisher, R.S. & I. Leppik. 2008. Epilepsia 49(Suppl 9): 7-12.
8. Fisher, R.S., W. van Emde Boas, W. Blume, et al. 2005. Epilepsia 46: 470-472.
9. Bladin, C. F., A. V. Alexandrov, A. Bellavance, et al. 2000. Arch. Neurol. 57: 1617-1622.
10. Silverman, I.E., L. Restrepo & G.C. Mathews. 2002. Arch. Neurol 59: 195-201.
11. Leonard, A.S. & J.O. McNamara. 2007. Neuron 55:677-678.
12. Kelly, K.M., N.L. Nadon, J.H. Morrison, et al 2006. Epilepsy Res. 68S: S5-S20.
13. Seyfried, T.N., G.H. Glaser, R.K. Yu & S.T. Palayoor. 1986. Adv. Neurol. 44: 115-133.
14. Geinisman, Y., L. de Toledo-Morrell, F. Morrell & R.E. Heller. 1995. Prog. Neurobiol. 45: 223-252.
15. Du, A.T., N. Schuff, D. Amend, et al 2001. J. Neurol. Neurosurg. Psych. 71: 441-447.
16. Barnes, C.A. 2001. Int. Rev. Neurobib. 45: 339-354.
17. Shankar, S., &c T.J. Teyler. 1998. Robbins. Neurophysiol. 79: 334-341.
18. de Toledo-Morrell, L. & F.S. Morrell. 1984. Behav. Neurosci. 98: 902-907.
19. Leppik, I.E., K.M. Kelly, L. de Toledo-Morrell, et al. 2006. Epilepsy Res. 68S: S21-S37.
20. Hartings J.A., A.J. Williams & F.C. Tortella. 2003. Exp. Neurol. 179: 139-149.
21. Karhunen H., A. Pitkanae, T. Virtanen, et al 2003. Epilepsy Res. 54.
22. DeLorenzo, R.J., D.A. Sun, & D. LS. 1998. Proc. Natl. Acad. Sci. USA 95: 14482-14487.
23. Palop, J.J., J. Chin, E.D. Roberson, et al 2007. Neuron 55: 697-711.
24. Rowan, A.J., R.E. Ramsay, J.F. Collins, et al 2005. Neurology 64: 1868-1873.
25. Hauser, W.A. 1992. Epilepsia 33(Suppl 4): S6-S14.
26. Gupta, S.R., M.H. Naheedy, D. Elias & F.A. Rubino. 1988. Stroke 19: 1477-1481.
27. Holmes, G. 1980. Clin. Electroencephalogrl. 11: 83-86.
28. Holmes, G.L. 1980. Clin. Electroeneephalogr. 11: 83-86.
29. Ensrud, K.E., T.S. Walczak, T.L. Blackwell, et al. 2008. Neurology 71: 723-730.
30. Ensrud, K.E., T.S. Walczak, T. Blackwell, et al. 2004. Neurology 62: 2051-11057
31. Leppik, I.E. 2006. Epilepsy Res. 68(Suppl 1): S1-S4.
32. Leppik, I.E., M.J. Brodie, E.R. Saetre, et al. 2006. Epilepsy Kes. 68(Suppl 1): S71-S76.
33. Moore, S.A. & T.W. Teal. 1985. Adverse drug reaction surveillance in the geriatric population: a preliminary review. In Proceedings of the Drug Information Association Workshop Geriatric Drug Use: Clinical and Social Perspectives. Pergamon Press. Washington, DC.
34. Perucca, E., D. Berlowitz, A. Birnbaum, et al. 2006. Epilepsy Res. 68(Suppl 1): S49-S63.
35. Pugh, M., J. Cramer, J. Knoefel, et al. 2003. J. Am. Geriatr. Soc. 52: 417-422.
36. Kemper, P. & C.M. Murtaugh. 1991. N. Engl. J. Med. 324: 595-600.
37. Hetzel, L. & A. Smith. 2001. The 65 years and over population: 2000, Census 2000 Brief; Census Bureau, C2KBR/01-10. Washington, DC.
38. Garrard, J., S. Harms, N. Hardie, et al. 2003. Ann. Neurol. 54: 75-85.
39. Galimberti, C.A., F. Magri, B. Magnani, et al. 2006. Epilepsy Res. 68: 1-8.
40. Lackner, T.E., J.C. Cloyd, L.W. Thomas & I.E. Leppik. 1998. Epilepsia 39: 1083-1087.
41. Wallace, S. & R. Verbeeck. 1987. Clin. Pharmacokinet. 12: 91-97.
42. Greenblatt, D.J. 1979. J. Am. Geriatr. Soc. 27: 20-22.
43. Verbeeck, R.K., J.A. Cardinal & S.M. Wallace. 1984. Eur. J. Clin. Pharmacol 27: 91-97.
44. Wynne, H.A., L.H. Cope, E. Mutch, et al. 1989. Hepatology 9:297-301.
45. Tiula, E. & P.J. Neuvonen. 1982. N. Engl. J. Med. 307: 1148.
46. Cusack, B.J. 1988. J. Clin. Pharmacol. 28: 571-576.
47. Dawling, S. & P. Crome. 1989. Clin. Pharmacokinet. 17: 236-263.
48. Ahn, J.E., J.C. Cloyd, R.C. Brundage, et al. 2008. Neurology 71:38-43.
49. Rowe, J.W., R. Andres, J.D. Tobin, et al. 1976. J. Gerontol. 31: 155-163.
50. Fehrman-Ekholm, I. & L. Skeppholm. 2004. Scand. J. Urol. Nephrol. 38: 73-77.
51. Ahn, J., J. Cloyd, R. Brundage, et al. 2008. Neurology 71: 38-43.
52. Leppik, I.E., J.D. Cloyd, R.J. Sawchuk & S.M. Pepin. 1979. Ther. Drug. Mon. 1: 475-483.
53. Graves, N.M., G.B. Holmes & I.E. Leppik. 1988. Epilepsy Res. Suppl. 1: 91-99.
54. Mooradian, A.D., L. Hernandez, I.C. Tamai & C. Marshall. 1989. Arch. Intern. Med. 149: 890-892.
55. Birnbaum, A., N.A. Hardie, I.E. Leppik, et al. 2003. Neurology 60: 555-559.
56. Ramsay, R., A. Rowan, J. Slater, et al 1994. Epilepsia 35: 91.
57. Brodie, MJ., P.W. Overstall & L. Giorgi. 1999. Epilepsy Res. 37: 81-87.
58. Mattson, R.H., J.A. Cramer, J.F. Collins, et al. 1985. N. Engl. J. Med. 313: 145-151.
59. Bauer, L.A. & R.A. Blouin. 1982. Clin. Pharmacol. Ther. 31: 301-304.
60. Birnbaum, A.K., N.A. Hardie, J.M. Conway, et al. 2003. Am. J. Geriatr. Pharmacother. 1: 90-95.
61. Leppik, I.E. 2006. Contemporary Diagnosis and Management of the Patient with Epilepsy, 6th edn. Handbooks in Healthcare. Newton, PA.
62. Nelson, M.H., A.K. Birnbaum & R.P. Remmel. 2001. Epilepsy Res. 44: 71-82.
63. Thompson, P., F.A. Huppert & M. Trimble. 1981. Br. J. Clin. Psychol. 20: 155-162.
64. Bourdet, S.V., B.E. Gidal & B.K. Alldredge. 2001. J. Am. Pharm. Assoc. (Wash.) 41: 421-1136
65. Bohannon, A.D., J.T. Hanlon, R. Landerman & D.T. Gold. 1999. Am. J. Epidemiol 149: 1002-1009.
66. Mattson, R.H., J.A. Cramer & J.F. Collins. 1992. N. Engl. J. Med. 327: 765-771.
67. Cloyd, J.C., T.E. Lackner & I.E. Leppik. 1994. Arch. Fam. Med. 3: 589-598.
68. Graves, N.M., R.C. Brundage, Y. Wen, et al. 1998. Pharmacotherapy 18: 273-281.
69. Birnbaum, A.K., J.M. Conway, N.A. Hardie, et al. 2007. Epilepsy Res. 77: 31-35.
70. Henry, D.A., D.H. Lawson, P. Reavey & S. Renfrew. 1977. Br. Med. J. 1: 83-84.
71. Dong, X., I.E. Leppik, J. White & J. Rarick. 2005. Neurology 65: 1976-1978.
72. Bryson, S.M., N. Verma, P.J. Scott & P.C. Rubin. 1983. Br. J. Clin. Pharmacol. 16: 104-105.
73. Perucca, E., R. Grimaldi, G. Gatti, et al. 1984. Br. J. Clin. Pharmacol. 17: 665-669.
74. Birnbaum, A.K., N.A. Hardie, J.M. Conway, et al 2004. Epilepsy Res. 62: 157-162.
75. Richens, A., C.R. Banfield, M. Salfi, et al. 1997. Br. J. Clin. Pharmacol. 44: 129-134.
76. Richens, A. 1993. Clinical Pharmacokinetics of Gabapentin. Royal Society of Medicine Services. London.
77. Peck, A.W. 1991. Epilepsia 32(Suppl 2): S9-S12.
78. Hussein, Z. & J. Posner. 1997. Br. J. Clin. Pharmacol. 43: 457-465.
79. Rowan, A., R. Ramsay, J. Collins, et al. 2005. Neurology 64: 1868-1873.
80. Yuen, A.W., G. Land, B.C. Weatherley & A.W. Peck. 1992. Br. J. Clin. Pharmacol. 33: 511-513.
81. Patsalos, RN. & J.W. Sander. 1994. Drug. Saf. 11: 37-67.
82. French, J. 2001. Epilepsia 42(Suppl 4): 40-43.
83. Morrell, M.J., I. Leppik, J. French, et al 2003. Epilepsy Res. 54: 153-161.
84. Cramer, J.A., I.E. Leppik, K.D. Rue, et al. 2003. Epilepsy Res. 56: 135-145.
85. Faigle, J.W. & M.G. 1990. Behav. Neurol. 3: 21-30.
86. van Heiningen, P.N., M.D. Eve, B. Oosterhuis, et al. 1991. Clin. Pharmacol. Ther. 50: 410-419.
87. Klosterskov Jensen, P., V. Saano, P. Haring, et al 1992. Epilepsia 33: 1149-1152.
88. Zaceara, G., P.F. Gangemi, L.Bendoni, et al. 1993. Ther. Drug. Monit. 15: 39-42.
89. Sachdeo, R.C., S.K. Sachdeo, S.A. Walker, et al 1996. Epilepsia 37: 774-780.
90. Levy, R., F. Bishop, A. Streeter, et al 1995. Epilepsia 36.
91. Leppik, I.E., L.J. Willmore, R.W Homan, et al. 1993. Epilepsy Res. 14: 165-173.
92. Wroe, O. 2007. Curr. Med. Res. Opin. 23: 1765-1773.
93. Nation, R.L., A.M. Evans & R.W. Milne. 1990. Clin. Pharmacokinet 18: 131-150.
94. Nation, R.L., A.M. Evans & R.W. Milne. 1990. Clin. Pharmacokinet. 18: 37-60.
95. Bollini, P., R. Riva, F. Albani, et al 1983. Epilepsia 24: 75-78.
96. Neef, C. & I. de Voogd-van der Straaten. 1988. Clin. Pharmacol. Ther. 43: 372-375.
97. Haley, C.J. & J. Nelson. 1989. Dicp-Ann Pharmacother 23: 796-798.
98. Sandor, P., E.M. Sellers, M. Dumbrell & V. Khouw. 1981. Clin. Pharmacol. Ther. 30: 390-397.
99. Cold, J.A., B.G. Wells & J.H. Froemming. 1990. Dicp Ann. Pharmacother. 24: 601-606.
100. Birnbaum, A., N. Hardie, I. Leppik, et al. 2003. Neurology 60: 555-559.